Article
Diagnostic and therapeutic advances in growth hormone insensitivity.
Endocrinology and metabolism clinics of North America - 1 Sept 2005
David Alessia, Metherell Louise A, Clark Adrian J L, Camacho-Hübner Cecilia, Savage Martin O
Abstract excerpt
Diagnostic and therapeutic advances in growth hormone insensitivity (GHI) have occurred principally in two areas: the molecular characterization of patients with GHI and treatment with recombinant human insulin like growth factor-I (IGF-I). This article discusses the current status of molecular diagnosis across the spectrum of the disorder. Treatment with recombinant human IGF-I in classical cases is summarized,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
